GlassScriptPhysician profile
Coleen Collins
NPI 1568810976
$5,992.98
in general payments reported to CMS, 2019-2025
16 companies · $1,502 in 2025
The $1,502 reported for 2025 was more than what 88% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $637 · 2022: $1,011 · 2023: $1,822 · 2024: $1,020 · 2025: $1,502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,331 · Education: $14.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,330.52 |
| Education | $14.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,928.36 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $823.95 | 2021-2025 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Alkermes, INC. | $588.31 | 2021-2025 | Aristada, Lybalvi |
| Neurocrine Biosciences, INC. | $583.61 | 2021-2025 | Ingrezza |
| Janssen Pharmaceuticals, INC | $423.88 | 2021-2025 | Invega Sustenna |
| Axsome Therapeutics, INC. | $360.71 | 2023-2025 | Auvelity |
| Vanda Pharmaceuticals INC. | $309.83 | 2021-2025 | Fanapt, Hetlioz |
| E.R. Squibb & Sons, L.L.C. | $213.80 | 2024-2025 | Cobenfy |
| Teva Pharmaceuticals USA, INC. | $211.66 | 2021-2025 | Uzedy, Austedo Xr, Austedo |
| Lundbeck LLC | $183.26 | 2021-2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $160.15 | 2021-2025 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $73.42 | 2021-2025 | Trintellix |
| Indivior INC. | $73.34 | 2022-2024 | Perseris |
| Collegium Pharmaceutical, INC. | $21.03 | 2025 | Jornay Pm |
| Almatica Pharma LLC | $19.95 | 2023 | Loreev Xr |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $17.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Coleen Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.